Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 May 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 May 2024 to 16 May 2024

Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 May 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 May 2024 to 16 May 2024

Human medicines European public assessment report (EPAR): Olanzapine Mylan, olanzapine, Date of authorisation: 06/10/2008, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Olanzapine Mylan, olanzapine, Date of authorisation: 06/10/2008, Revision: 20, Status: Authorised

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1

Products Management Services - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe: Introduction - EU Implementation Guide

Products Management Services - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe: Introduction - EU Implementation Guide

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.